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Abstract
Objective—Evaluate precautionary practices and extent of use of ethylene oxide (EtO) and 
hydrogen peroxide gas plasma (HPGP) sterilization systems, including use of single chamber EtO 
units.
Design—Modular, web-based survey.
Participants—Members of professional practice organizations who reported using EtO or HPGP 
in the past week to sterilize medical instruments and supplies. Participating organizations invited 
members via email which included a hyperlink to the survey.
Methods—Descriptive analyses were conducted including simple frequencies and prevalences.
Results—A total of 428 respondents completed the module on chemical sterilants. Because most 
respondents worked in hospitals (87%, n=373) analysis focused on these workers. Most used 
HPGP sterilizers (84%, n=373), 38% used EtO sterilizers, with 22% using both. Nearly all 
respondents using EtO operated single chamber units (94%, n=120); most of them reported that 
the units employed single use cartridges (83%, n=115). Examples of where engineering and 
administrative controls were lacking for EtO include: operational local exhaust ventilation (7%; 
n=114); continuous air monitoring (6%; n=113); safe handling training (6%; n=142); and standard 
operating procedures (4%; n=142). Examples of practices which may increase HPGP exposure 
risk included lack of standard operating procedures (9%; n=311) and safe handling training (8%; 
n=312).
Conclusions—Use of precautionary practices was good but not universal. EtO use appears to 
have diminished in favor of HPGP which affords higher throughput and minimal regulatory 
constraints. Separate EtO sterilization and aeration units were still being used nearly one year after 
U.S. EPA prohibited their use.
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Introduction
Sterilization has been done for many decades in healthcare settings and is essential to ensure 
surgical instruments and medical supplies do not transmit infectious pathogens to patients. 
Although steam sterilization is highly effective and environmentally friendly, the 
introduction of heat and/or moisture sensitive medical devices prompted the development of 
low temperature chemical sterilization methods. Ethylene oxide (EtO) was first used as a 
chemical sterilant in healthcare settings in the 1950s.1 Because of stringent health, safety 
and environmental regulatory requirements and lengthy processing times, ‘safer’ and more 
expedient alternatives have since been introduced. These include hydrogen peroxide gas 
plasma (HPGP), vaporized hydrogen peroxide, and immersion and vapor phase peracetic 
acid.2 Sterilizers utilizing steam, EtO, and HPGP are predominantly used in high throughput 
applications typically found in hospital central sterile supply (CSS) departments. These and 
other chemical sterilants are also used to a lesser extent in point-of-use applications.
EtO sterilization systems commonly found in hospitals utilize EtO from 2 sources: 1) single 
use cartridges of 100% EtO, and 2) compressed gas cylinders or tanks of 100% EtO or EtO 
mixed with chlorofluorocarbons (CFCs) or carbon dioxide (CO2). Use of EtO mixtures has 
decreased following the ban of ozone-depleting CFCs in the mid-1990s and stability and 
pressure issues associated with CO2. Single use cartridges eliminate exposure risks 
associated with piping leaks and cylinder changes because they are punctured automatically 
while enclosed in the sterilizer unit.1 Cycle times, including sterilization and aeration, can 
range from 10.5 to 14.5 hours.2
EtO sterilization requires a lengthy (8 to 12 hours) aeration to purge EtO from treated 
materials so that they do not harm patients or workers. When sterilization and aeration are 
done in separate units, healthcare workers can be exposed to EtO when transferring off-
gassing loads from the sterilizer to the aerator. As a means of lowering ambient workplace 
EtO levels and reducing long-term non-cancer and potential cancer risks associated with 
exposure to EtO, the U.S. Environmental Protection Agency (EPA) required hospitals and 
healthcare facilities to use a single chamber process for EtO which combines sterilization 
and aeration in a single unit.3 This requirement became effective on March 1, 2010, 
following an initial announcement in March 2008 which allowed time for employers to 
comply.4 Additionally, state or local regulations may require that EtO emissions from the 
aeration process be treated with an air pollution control device.
Sterilization using HPGP is considered an environmentally safer and more time-efficient 
alternative to EtO with cycle times of 75 minutes.2 One of the first sterilizer systems using 
HPGP approved by the U.S. Food and Drug Administration was the SterradTM system.5 
Under normal conditions, operator contact with either the liquid or plasma hydrogen 
peroxide is negligible; liquid hydrogen peroxide is contained in a sealed cassette which is 
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punctured only after the sterilizer door is closed. By-products include water and oxygen 
which are nontoxic and eliminate the need for aeration.2
Acute exposure to EtO may result in respiratory irritation, headache, nausea, coughing, 
shortness of breath, and cyanosis.6 Chronic exposure to EtO has been associated with the 
occurrence of cancer, reproductive effects, mutagenic changes, neurotoxicity, and 
sensitization.6 Occupational exposure in healthcare facilities has been linked to an increased 
risk of spontaneous abortions and various cancers.7–9 Injuries (e.g., tissue burns) to patients 
have been associated with EtO residues in implants used in surgical procedures.10 The 
International Agency for Research on Cancer (IARC) has determined that EtO is 
carcinogenic to humans.11,12 The National Institute for Occupational Safety and Health 
(NIOSH) recommends that EtO be regarded as a potential occupational carcinogen in the 
workplace.9 Guidelines for the safe use and handling of EtO including recommended 
engineering controls, personal protective equipment (PPE), and work practices have been 
published by NIOSH and the Occupational Safety and Health Administration (OSHA).13,14
Occupational exposure to hydrogen peroxide primarily occurs via inhalation and contact 
with the skin and eyes. In a food sterilization process, inhalation of hydrogen peroxide 
vapors caused irritation of the eyes, nose and throat of exposed workers.15 Irritation and 
redness of the skin can develop following contact with liquid solutions; burns with blisters 
have developed following exposure to concentrated solutions. Eye contact with liquid 
hydrogen peroxide causes irritation and redness; corneal ulcerations have developed 
following contact with concentrated solutions.16 Inadequate evidence exists of the 
carcinogenicity of hydrogen peroxide in humans.17
The primary objective of this study was to describe exposure control practices used to 
minimize exposures to EtO and HPGP, characterize the extent of use of EtO and HPGP 
sterilization, and assess compliance with EPA’s requirement for employers to use a single 
chamber process for EtO.
METHODS
Survey Methodology
The NIOSH Health and Safety Practices Survey of Healthcare Workers was a voluntary, 
anonymous, modular web-based survey conducted in early 2011. The study population 
primarily included members of professional practice organizations representing central 
supply technicians. Participating organizations invited members via email which included a 
hyperlink to the survey. Practices associated with the use of high level disinfectants in point-
of-use applications were addressed in a separate hazard module and reported elsewhere.18 
Methods used to develop, test and implement the survey, along with its strengths and 
limitations, have been published previously.19
Survey Instrument
The web survey instrument included a screening module, 7 hazard modules addressing 
selected chemical hazards commonly found in healthcare settings, and a core module. 
Participants were eligible to complete the hazard module on chemical sterilants if they 
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responded ‘yes’ to the screening question asking whether they used EtO or HPGP to 
chemically sterilize medical or dental devices, instruments or supplies during the past 7 
calendar days (hereafter referred to as the past week). It was possible for respondents to 
complete the chemical sterilants hazard module and not the core module. In those cases, 
demographic information is unavailable.
Most questions were presented to all respondents. However, questions addressing PPE, 
medical surveillance, and personal exposure monitoring were presented only to respondents 
who used automated EtO sterilizers with compressed gas cylinders or manual sterilizers 
utilizing glass ampules containing liquid EtO because these systems present the greatest 
potential for EtO exposure. The format of the questions varied including multiple choice, 
multi-part, yes/no and numeric. The questions sought information relative to the past week 
unless otherwise noted. To minimize response error, photos were included of various types 
of respirators.
Data Analysis
Data were analyzed using SAS 9.3.20 Simple frequencies and prevalences are presented. 
Stratification was used to further describe and compare and contrast extent of use and 
process characteristics of EtO and HPGP. Results include responses to questions in the 
chemical sterilants module and selected questions in the core module that describe 
demographic, employer and occupation characteristics. Age was estimated by subtracting 
respondents’ year of birth from the year the survey took place, 2011. States where 
respondents worked were aggregated into 4 U.S. Census regions (Northeast, Midwest, South 
and West). No a priori hypotheses were proposed therefore statistical tests were not 
performed.
Human Subjects Review
The NIOSH Institutional Review Board determined that the activities in this project were 
surveillance and did not meet the criteria of research according to 45 CFR 46.1101(b)(2) and 
CDC Guidelines for Defining Public Health Research and Public Health Nonresearch.21
RESULTS
Respondent Characteristics
There were 428 respondents who sterilized medical instruments and supplies using EtO 
(n=142) and/or HPGP (n=313) during the past week. Of these, 373 (87%) reported that they 
most often sterilized in hospitals, predominantly in the CSS department (92%) or in other 
hospital areas (8%). The remaining respondents who sterilized in non-hospital settings (e.g. 
outpatient care centers, physician and dental offices) were excluded from the analysis 
because there were relatively few in each setting for meaningful interpretation of the data.
Nearly all (98%) of the 373 respondents who worked in hospitals completed the core 
module and are characterized by demographic and other descriptive information. 
Respondents were predominantly female (72%), non-Hispanic (91%) and older than 40 
years of age (81%). The majority of respondents were white (81%); some reported that they 
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were black (15%), Asian (3%) or another race (4%). Education level varied, with most 
reporting up to Grade 12 (38%) or having either a vocational certificate (26%) or 
Associate’s degree (20%). One-sixth (17%) were members of labor unions.
Respondents primarily categorized themselves as technicians/technologists including central 
supply processing technicians, sterile technicians and surgical technologists (90%); nurses 
(7%) and other healthcare workers (Table 1). Two-thirds of respondents (67%) had 6 or 
more years of experience in their current occupation, and 61% reported working for their 
current employer for 10 years or less. Seventy-one percent of employers had 250 or more 
employees. Most employers (57%) were non-profit; 31% were for-profit with the remaining 
employers being publicly-owned establishments. Respondents worked in states equally 
represented by the 4 major U.S. Census regions and over half (57%) worked in a large city.
Training, Professional Certification, Availability of Employer Procedures and Familiarity 
with OSHA Guidelines
Nearly all respondents using EtO were trained (94%), reported that their employer had 
standard procedures for sterilizing with EtO (96%), and were familiar with OSHA 
guidelines (94%) (Table 2). Of those trained, 40% reported that it had been more than 12 
months ago. By comparison, a slightly lower proportion of respondents who used HPGP was 
trained (92%) and reported that their employer had standard procedures (91%). Of the 
HPGP users who had received training, almost half (46%) reported that it had been more 
than 12 months ago. Most respondents using EtO and/or HPGP reported that they had 
achieved professional certification (88%). Primary sources included the International 
Association of Healthcare Central Service Materiel Management and the Certification Board 
for Sterile Processing and Distribution.
EtO and HPGP System Characteristics
When asked about the type of sterilization system used, 84% of respondents reported HPGP, 
38% EtO, and 22% used both (Table 3). Most (94%) respondents using EtO operated single 
chamber units, though a small number (6 respondents) reported using separate sterilization 
and aeration units. Of those who operated single chamber units, most (83%) reported that 
the EtO source was single-use cartridges instead of compressed gas cylinders. All 6 
respondents who operated separate units for EtO sterilization and aeration reported that the 
sterilizer units used single-use cartridges. Five of these respondents reported that 
transferring loads from the sterilizer to the aerator lasted no more than 2 minutes and 1 
reported that it lasted more than 6 minutes (Table 3).
Additional characteristics are presented separately for EtO and HPGP sterilization processes, 
including number of years the respondent had been chemically sterilizing medical 
instruments and supplies, number of days sterilizing and number of loads processed in the 
past week, and whether the number of loads processed were typical (Table 3). Marked 
differences were noted—EtO sterilization systems were used by respondents for more years, 
but for fewer days and loads in the past week compared to HPGP. Of the respondents using 
EtO, over a third (37%) sterilized for 11 or more years, nearly half (48%) sterilized for 2 or 
fewer days in the past week, and 56% processed 3 or fewer loads per week. By comparison, 
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most respondents (83%) using HPGP sterilized for 10 or fewer years, 56% sterilized for 5 or 
more days in the past week, and over half (52%) processed more than 11 loads per week. 
Between 80% and 90% of each group reported that the number of loads processed was the 
same as usual; however, a slightly greater proportion of respondents using HPGP reported 
that the number of loads processed was fewer than usual (13% vs 7%).
Administrative and Engineering Controls for EtO
Respondents who used both types of EtO sterilizer systems (i.e., single chamber unit and 
separate sterilization and aeration units) were asked about specific engineering and 
administrative controls including the presence of local exhaust ventilation (LEV) above the 
sterilizer door, continuous EtO air monitors near the sterilizer, and whether gas cylinders 
were located in a different room than the sterilization process (Table 4). Seven percent of 
respondents using single chamber EtO sterilizers reported that LEV was not present above 
the door of the unit, while an additional 19% who did not know. Six percent of respondents 
using single chamber EtO sterilizers reported that a continuous EtO monitor was not located 
near the sterilizer and 6% did not know. Over a third of respondents (37%) reported that the 
gas cylinders for the single chamber sterilizers were located in the same room as the 
sterilizer. Of the 6 respondents who reported using EtO sterilization systems with separate 
aeration chambers, 4 reported that LEV was present above the sterilizer door (2 did not 
know) and 3 reported that a continuous EtO monitor was present near the sterilizer (3 did 
not know).
Respiratory Protection for EtO
Only respondents using EtO units with compressed gas cylinders (n=19) were queried 
regarding the use of respiratory protection. Mistakenly excluded from these questions were 
the 6 respondents who used separate units for sterilization and aeration. None of the 19 
respondents reported using a respirator while operating the EtO unit, although 4 reported 
using a surgical mask. Primary reasons for not wearing respirators included “an engineering 
control was being used” (50%), “exposure was minimal” (33%), and “not part of our 
protocol” (28%).
Medical Surveillance and Exposure Monitoring
Questions about participation in a medical surveillance program and exposure monitoring 
were presented only to respondents who used EtO and, of these, only to those (n=19) who 
operated units using compressed gas cylinders. The 6 respondents using EtO systems with 
separate sterilization and aeration were inadvertently excluded as noted above. A medical 
surveillance program, as defined in the survey, may include a work history, physical exam, 
and blood and/or urine tests. There was no medical surveillance of the 19 respondents. Eight 
of the respondents (42%) reported that their employer did not provide such a program, 9 
(47%) were unaware whether their employer had a program, and 2 (11%) opted out of 
participating in their program.
Respondents (n=19) were asked whether or not exposure monitoring had been conducted in 
the past 12 months to assess personal or co-worker exposure to EtO. Thirty-seven percent 
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reported “it had”, 42% reported “it had not” and 21% were unaware whether or not it had 
been done.
DISCUSSION
This survey is one of the first to characterize precautionary practices and extent of use of 
EtO and HPGP sterilization systems in hospitals. The timing of the survey (January–March 
2011) also afforded the opportunity to evaluate compliance with EPA’s requirement that a 
single chamber unit be used when sterilizing medical equipment with EtO which became 
effective on March 1, 2010.
With the exception of the 6 respondents who reported using separate units for EtO 
sterilization and aeration, all of the EtO and HPGP sterilization systems used in hospitals 
were automated closed-system processes which, under normal operating conditions and 
proper maintenance, represent minimal exposure risk to healthcare workers. Our survey did 
not ask respondents whether or not there were any equipment malfunctions in the recent past 
that activated alarms or resulted in acute health problems, whether or not environmental 
monitoring had been conducted for HPGP sterilizers, and information about the performance 
and maintenance of LEV systems. This information should be included in future studies.
Our survey showed that more than twice as many respondents reported using HPGP vs EtO 
sterilizers. This was not unexpected considering the regulatory constraints for EtO, coupled 
with sterile processing advantages of HPGP (much shorter processing times and harmless 
by-products including water vapor and oxygen). Operational advantages of HPGP were 
borne out in the data—respondents using HPGP sterilizers processed a much greater number 
of loads and spent more days per week sterilizing than those using EtO sterilizers.
Precautionary practices primarily focused on EtO because OSHA and EPA have regulations 
specifying the types of equipment and procedures that are needed to minimize worker 
exposure and ambient workplace EtO levels.3, 14 Most respondents sterilizing with EtO used 
single chamber units that employed single use cartridges which are considered “safer” 
systems relative to minimizing potential EtO exposure risk. Most respondents also reported 
that a continuous EtO air monitor was present near the sterilizer to warn of high EtO levels 
in the event of a leak or equipment problem, and that (operational) LEV was present above 
the sterilizer door to remove fugitive EtO emissions. Additionally, two-thirds of the 
relatively few respondents who operated EtO sterilizers with compressed gas cylinders 
reported that the cylinders were in a different room than the sterilizer, which is a 
recommended practice to minimize worker exposure in the event a leak occurs in the gas 
line, valves or connections. Nearly all respondents using EtO sterilizers were trained, 
certified, and aware of OSHA procedures, and stated that their employer had standard 
sterilization procedures.
As noted earlier, 6 respondents (5%) reported using separate units for EtO sterilization and 
aeration, which is not in compliance with EPA’s single chamber mandate. The problem with 
this type of equipment is the potential for relatively high EtO levels that typically occur 
during the transfer of (off-gassing) loads from the sterilizer to the aerator. Although use of 
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precautionary practices focused on EtO, practices which may increase HPGP exposure risk 
included lack of safe handling training and employee-reported standard procedures.
According to the OSHA ethylene oxide standard (29CFR 1910.1047) employers must 
perform initial exposure monitoring of workers, and periodic exposure monitoring if either 
8-hour exposures are at or above the action level or short-term exposures are at or above the 
15 minute excursion limit. Additionally, employers are required to have a medical 
surveillance program for workers who are or may be exposed to EtO at or above the action 
level for at least 30 days a year. Some respondents reported that their employer conducted 
exposure monitoring during the past 12 months; however, most reported that it had not been 
done or they did not know if it had. A small proportion of respondents reported that medical 
monitoring was provided by employers but they did not participate in the program; most 
reported that their employer did not have a medical surveillance program or they did not 
know if one was available. We did not ask respondents why exposure monitoring was not 
conducted or why medical monitoring was not provided. It is unclear whether employers did 
not have a medical surveillance program because EtO levels were below the action level or 
were not in compliance with the standard.
Limitations of the study need to be considered when interpreting survey findings. The 
survey was targeted to professional practice organizations whose members are likely to use 
or come in contact with the chemical agents under investigation. Response rate could not be 
calculated because the survey invitation specified the specific chemical agents under study; 
it is not known who decided not to participate because they did not use any of the chemicals 
and therefore were ineligible, versus those who used them but decided not to participate for 
other reasons. Because the survey was not a probability sample, the findings and conclusions 
are not generalizable to all healthcare workers who sterilize using HPGP or EtOs but are 
limited to healthcare workers who participated. Additionally, the delivery of and response to 
the survey was conducted electronically, limiting respondents to those who have e-mail and 
Internet access. Survey data are self-reported and responses were not confirmed via 
observation, records or other means. Information on use of specific exposure controls, and 
medical and exposure monitoring were lacking for respondents who used separate EtO 
sterilization and aeration units, albeit only reported by 6 respondents. Information on 
reasons for absence of exposure and medical monitoring was not collected and should be 
evaluated in future studies.
In conclusion, although the survey does not represent all healthcare workers who sterilize 
with HPGP and EtO, the survey provides valuable information on current use and 
precautionary practices used to minimize exposures in hospitals. Survey findings show: 1) 
use of precautionary practices for EtO and HPGP sterilization processes was good but not 
universal; 2) a few separate EtO sterilization and aeration units were still in use one year 
after EPA mandated switching to single chamber units; and 3) EtO use appears to have 
diminished in favor of HPGP which affords higher throughput and minimal regulatory 
constraints.
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Table 1
Occupation and Employer Characteristics of Respondents
Characteristic % of Respondents
Occupation (n*=360)
 Technician/technologist 90
 Nurse 7
 Other 3
Years in current occupation (n=358)†
 < 1 4
 1–5 29
 6–10 20
 11–20 24
 21–30 16
 >30 7
Years with current employer (n=358)†
 <1 7
 1–5 34
 6–10 20
 11–20 29
 >20 18
Employer ownership type (n=349)†
 Non-profit 57
 For profit 31
 State, city, county or district government 7
 Federal government 5
Size of employer (# of employees) (n=357)
 <10 7
 10–99 15
 100–249 7
 250–1,000 27
 >1,000 44
Employer location by population density (n=357)†
 Large city (≥50,000 people) 57
 Small city (<50,000 people) 22
 Suburbs (areas adjacent to cities) 12
 Rural 10
Employer geographic region‡ (n=284)†
 South 25
 Midwest 27
 West 24
 Northeast 23
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*Number of respondents varied for individual items (i.e., number of eligible respondents less number who elected not to answer).
†
Percent totals do not add up to exactly 100 due to rounding.
‡
Based on four U.S. Census regions: Northeast = CT, ME, MA, NJ, NH, NY, PA, RI, VT; Midwest = IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, 
SD, WI; South = AL, AR, DE, DC, FL, GA, KY, LA, MD, MS, NC, OK, SC, TN, TX, VA, WV; West = AK, AZ, CA, CO, HI, ID, MT, NM, NV, 
OR, UT, WA, WY.
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Table 2
Training, Employer Standard Procedures and Familiarity with OSHA Guidelines
Training/Standard Procedures EtO HPGP
n % Yes n % Yes
Training on safe handling procedures 142 94 312 92
 >12 months ago 133 40 286 46
 ≤12 months 133 60 286 54
Employer has standard procedures 142 96 311 91
Familiar with OSHA guidelines 142 94
–
*
–
*
EtO= ethylene oxide; HPGP=hydrogen peroxide gas plasma
*
There are no OSHA guidelines for HPGP
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Table 3
Sterilization Process Characteristics
Process Characteristics % of Respondents
Type of sterilization system used (n*=373)†
 EtO 38
 HPGP 84
 EtO and HPGP 23
Type of EtO system used
 Single chamber (sterilization and aeration occur in same unit) 94 (n=124)‡
 Separate units for sterilization and aeration 5 (n=120)‡
Source of EtO for single chamber sterilizer (n=115)
 Single use cartridges 83
 Gas cylinders 17
Source of EtO for separate sterilization and aeration units (n=6)
 Single use cartridges 100
 Gas cylinders 0
Time (in minutes) transferring loads from sterilizer to aerator (n=6)
 < 1 50
 1–2 33
 >6 minutes 17
Process Characteristics by Type of Sterilization System EtO HPGP
Number of years sterilizing medical instruments and/or supplies (n=142)‡ (n=312)
 <1 6 6
 1–5 37 47
 6–10 19 30
 11–20 18 14
 >20 19 3
Number of days sterilizing medical instruments and/or supplies (n=142) (n=310)‡
 1 33 11
 2 15 13
 3 15 9
 4 9 10
 5 15 29
 6 or 7 13 27
Number of loads processed during past week§ (n¶=115) (n=308)‡
  EtO HPGP
  1 load <11 loads 31 47
  2–3 loads 11–20 loads 25 25
  4–5 loads 21–50 loads 22 18
  6–10 loads 51–100 loads 16 7
  >10 loads >100 loads 6 2
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Process Characteristics by Type of Sterilization System EtO HPGP
Number of loads processed compared to usual (n¶=115) (n=251)
 more loads than usual 6 5
 fewer loads than usual 7 13
 about the same number of loads as usual 87 82
EtO=ethylene oxide; HPGP=hydrogen peroxide gas plasma
*Number of respondents varied for individual items (i.e., number of eligible respondents less number who elected not to answer).
†
Percents add to more than 100 percent because respondents could select more than one answer.
‡
Percents do not add to exactly 100% due to rounding.
§Shorter processing times for HPGP compared to EtO was the basis for the higher load ranges
¶
Does not include respondents who used separate sterilization and aeration equipment due to small number (n=6).
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Table 4
Administrative and Engineering Controls For Single Chamber EtO Sterilizers
Administrative and Engineering Controls n % of Respondents
Yes No I don’t know
Operational LEV above sterilizer door 114* 74 7 19
Continuous monitor located near sterilizer that provides warning when EtO leaks occur 113* 88 6 6
Gas cylinder located in different room than sterilizer 19† 63 37 –
LEV=local exhaust ventilation; EtO=ethylene oxide
*Number of respondents varied for individual items (i.e., number of eligible respondents less number who elected not to answer)
†
Respondents who reported gas cylinders as the source for single chamber EtO sterilizers
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